Overall mean (SD) percentage scores in each AGREE II domain and mean (0–7 scale/SD) for each item
| Mean (SD) | |
| Domain 1: scope and purpose (%) | 72.4 (14.3) |
| 1. The overall objective(s) of the guideline is (are) specifically described. | 5.6 (.84) |
| 2. The health question(s) covered by the guideline is (are) specifically described. | 5.1 (1.1) |
| 3. The population (patients, public and so on) to whom the guideline is meant to apply is specifically described. | 5.3 (1.0) |
| Domain 2: stakeholder involvement (%) | 43.8 (18.0) |
| 4. The guideline development group includes individuals from all relevant professional groups. | 4.0 (1.3) |
| 5. The views and preferences of the target population (patients, public and so on) have been sought. | 2.2 (1.2) |
| 6. The target users of the guideline are clearly defined. | 4.7 (1.2) |
| Domain 3: rigour of development (%) | 47.2 (22.2) |
| 7. Systematic methods were used to search for evidence. | 4.7 (1.7) |
| 8. The criteria for selecting the evidence are clearly described. | 4.1 (1.9) |
| 9. The strengths and limitations of the body of evidence are clearly described. | 4.2 (1.7) |
| 10. The methods for formulating the recommendations are clearly described. | 3.8 (1.5) |
| 11. The health benefits, side effects and risks have been considered in formulating the recommendations. | 4.0 (1.3) |
| 12. There is an explicit link between the recommendations and the supporting evidence. | 4.5 (1.4) |
| 13. The guideline has been externally reviewed by experts prior to its publication. | 2.5 (1.5) |
| 14. A procedure for updating the guideline is provided. | 2.9 (2.0) |
| Domain 4: clarity of presentation (%) | 59.1 (17.7) |
| 15. The recommendations are specific and unambiguous. | 4.4 (1.1) |
| 16. The different options for management of the condition or health issue are clearly presented. | 4.5 (1.0) |
| 17. Key recommendations are easily identifiable. | 4.7 (1.3) |
| Domain 5: applicability (%) | 26.3 (19.5) |
| 18. The guideline describes facilitators and barriers to its application. | 2.4 (1.3) |
| 19. The guideline provides advice and/or tools on how the recommendations can be put into practice. | 3.5 (1.5) |
| 20. The potential resource implications of applying the recommendations have been considered. | 2.3 (1.3) |
| 21. The guideline presents monitoring and/or auditing criteria. | 2.1 (1.3) |
| Domain 6: editorial independence (%) | 32.5 (27.5) |
| 22. The views of the funding body have not influenced the content of the guideline. | 2.9 (1.7) |
| 23. Competing interests of guideline development group members have been recorded and addressed. | 3.0 (1.9) |
| Overall score (%) | 45.1 (19.7) |
AGREE, Appraisal of Guidelines for Research and Evaluation.